News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,607 Results
Type
Article (42667)
Company Profile (292)
Press Release (694636)
Multimedia
Podcasts (84)
Webinars (21)
Section
Business (208864)
Career Advice (2100)
Deals (36138)
Drug Delivery (112)
Drug Development (81957)
Employer Resources (174)
FDA (16787)
Job Trends (15310)
News (352530)
Policy (33251)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2647)
Accelerated approval (31)
Adcomms (24)
Allergies (139)
Alliances (51114)
ALS (168)
Alzheimer's disease (1671)
Antibody-drug conjugate (ADC) (309)
Approvals (17051)
Artificial intelligence (535)
Autoimmune disease (148)
Automation (37)
Bankruptcy (364)
Best Places to Work (11943)
BIOSECURE Act (21)
Biosimilars (189)
Biotechnology (186)
Bladder cancer (157)
Brain cancer (57)
Breast cancer (641)
Cancer (4811)
Cardiovascular disease (400)
Career advice (1774)
Career pathing (35)
CAR-T (284)
CDC (44)
Celiac Disease (2)
Cell therapy (744)
Cervical cancer (36)
Clinical research (69933)
Collaboration (1736)
Company closure (4)
Compensation (1153)
Complete response letters (55)
COVID-19 (2745)
CRISPR (90)
C-suite (838)
Cystic fibrosis (145)
Data (6195)
Decentralized trials (2)
Denatured (29)
Depression (131)
Diabetes (497)
Diagnostics (6876)
Digital health (46)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (254)
Drug pricing (186)
Drug shortages (28)
Duchenne muscular dystrophy (229)
Earnings (91140)
Editorial (56)
Employer branding (21)
Employer resources (153)
Events (119900)
Executive appointments (993)
FDA (19932)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1483)
Gene editing (195)
Generative AI (45)
Gene therapy (598)
GLP-1 (975)
Government (4719)
Grass and pollen (6)
Guidances (385)
Healthcare (19450)
HIV (56)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (246)
Immuno-oncology (57)
Indications (105)
Infectious disease (3010)
Inflammatory bowel disease (190)
Inflation Reduction Act (14)
Influenza (113)
Intellectual property (243)
Interviews (333)
IPO (16863)
IRA (49)
Job creations (3712)
Job search strategy (1474)
JPM (57)
Kidney cancer (15)
Labor market (84)
Layoffs (547)
Leadership (31)
Legal (8066)
Liver cancer (91)
Longevity (14)
Lung cancer (648)
Lymphoma (377)
Machine learning (43)
Management (59)
Manufacturing (794)
MASH (161)
Medical device (14321)
Medtech (14374)
Mergers & acquisitions (20359)
Metabolic disorders (1260)
Multiple sclerosis (161)
NASH (16)
Neurodegenerative disease (312)
Neuropsychiatric disorders (86)
Neuroscience (2896)
Neurotech (1)
NextGen: Class of 2026 (6786)
Non-profit (4609)
Now hiring (65)
Obesity (592)
Opinion (264)
Ovarian cancer (165)
Pain (205)
Pancreatic cancer (225)
Parkinson's disease (282)
Partnered (35)
Patents (492)
Patient recruitment (481)
Peanut (56)
People (60089)
Pharmaceutical (64)
Pharmacy benefit managers (29)
Phase 1 (21809)
Phase 2 (30781)
Phase 3 (22919)
Pipeline (5186)
Policy (283)
Postmarket research (2585)
Preclinical (9280)
Press Release (65)
Prostate cancer (237)
Psychedelics (47)
Radiopharmaceuticals (282)
Rare diseases (837)
Real estate (6127)
Recruiting (70)
Regulatory (24843)
Reports (51)
Research institute (2463)
Resumes & cover letters (364)
Rett syndrome (27)
RNA editing (18)
RSV (76)
Schizophrenia (147)
Series A (242)
Series B (194)
Service/supplier (15)
Sickle cell disease (96)
Special edition (21)
Spinal muscular atrophy (159)
Sponsored (44)
Startups (3682)
State (2)
Stomach cancer (17)
Supply chain (107)
Tariffs (84)
The Weekly (53)
Vaccines (1001)
Venture capital (89)
Weight loss (381)
Women's health (87)
Worklife (19)
Date
Today (116)
Last 7 days (645)
Last 30 days (2142)
Last 365 days (30385)
2026 (3041)
2025 (30708)
2024 (35815)
2023 (40718)
2022 (51910)
2021 (56548)
2020 (55219)
2019 (48042)
2018 (36226)
2017 (32889)
2016 (32392)
2015 (38432)
2014 (32080)
2013 (27125)
2012 (29377)
2011 (30003)
2010 (28010)
Location
Africa (760)
Alabama (85)
Alaska (7)
Arizona (308)
Arkansas (13)
Asia (40304)
Australia (6575)
California (11290)
Canada (3282)
China (1105)
Colorado (479)
Connecticut (476)
Delaware (337)
Europe (88239)
Florida (1674)
Georgia (367)
Hawaii (3)
Idaho (66)
Illinois (886)
India (66)
Indiana (525)
Iowa (23)
Japan (425)
Kansas (128)
Kentucky (40)
Louisiana (27)
Maine (72)
Maryland (1384)
Massachusetts (8151)
Michigan (344)
Minnesota (643)
Mississippi (6)
Missouri (137)
Montana (31)
Nebraska (28)
Nevada (125)
New Hampshire (79)
New Jersey (3013)
New Mexico (31)
New York (2984)
North Carolina (1492)
North Dakota (9)
Northern California (5489)
Ohio (347)
Oklahoma (23)
Oregon (43)
Pennsylvania (2272)
Puerto Rico (23)
Rhode Island (49)
South America (1154)
South Carolina (67)
South Dakota (1)
Southern California (4404)
Tennessee (174)
Texas (1769)
United States (40298)
Utah (343)
Vermont (1)
Virginia (265)
Washington D.C. (83)
Washington State (923)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
737,607 Results for "bone solutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance
November 10, 2025
·
9 min read
Press Releases
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
February 3, 2026
·
1 min read
Press Releases
Bone Solutions’ Mg OSTEOCRETE and Mg OSTEOINJECT Receive FDA Clearance for Pediatric Use in Patients Aged Six and Older
October 21, 2025
·
2 min read
Press Releases
Cerapedics’ PearlMatrix P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator, Now Approved for Expanded Indications for Use
January 14, 2026
·
6 min read
Press Releases
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
January 13, 2026
·
3 min read
Press Releases
Syncromune®, Inc. Presents Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at Society of Urological Oncology 26th Annual Meeting
December 4, 2025
·
7 min read
Press Releases
FDA Greenlights RevBio’s Pivotal Clinical Trial for its Cranial Flap Bone Glue
January 29, 2026
·
3 min read
Press Releases
Syncromune®, Inc. to Present Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at the Society of Urological Oncology 26th Annual Meeting
November 21, 2025
·
5 min read
Press Releases
Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution
January 8, 2026
·
6 min read
Phase III
Ultragenyx Loses $1B in Market Value as Bone Drug Fails To Reduce Fractures
With a pair of Phase III trial flops, Ultragenyx will explore cost reductions as analysts turn attention to an upcoming Angelman syndrome readout.
January 2, 2026
·
2 min read
·
Annalee Armstrong
1 of 73,761
Next
